GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » NanoRepro AG (XTER:NN6) » Definitions » Asset Impairment Charge

NanoRepro AG (XTER:NN6) Asset Impairment Charge : €0.00 Mil (TTM As of Jun. 2024)


View and export this data going back to 2008. Start your Free Trial

What is NanoRepro AG Asset Impairment Charge?

NanoRepro AG's Asset Impairment Charge for the six months ended in Jun. 2024 was €0.00 Mil. Its Asset Impairment Charge for the trailing twelve months (TTM) ended in Jun. 2024 was €0.00 Mil.


NanoRepro AG Asset Impairment Charge Historical Data

The historical data trend for NanoRepro AG's Asset Impairment Charge can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

NanoRepro AG Asset Impairment Charge Chart

NanoRepro AG Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Asset Impairment Charge
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

NanoRepro AG Semi-Annual Data
Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Asset Impairment Charge Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

NanoRepro AG Asset Impairment Charge Calculation

Asset Impairment Charge is the charge against earnings resulting from the aggregate write down of all assets from their carrying value to their fair value.

Asset Impairment Charge for the trailing twelve months (TTM) ended in Jun. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was €0.00 Mil.


NanoRepro AG Asset Impairment Charge Related Terms

Thank you for viewing the detailed overview of NanoRepro AG's Asset Impairment Charge provided by GuruFocus.com. Please click on the following links to see related term pages.


NanoRepro AG Business Description

Traded in Other Exchanges
Address
Untergasse 8, Marburg, DEU, 35037
NanoRepro AG is engaged in the development, manufacturing, and distribution of CE-certified rapid diagnostic tests (self-tests) and food supplements for both, home and professional use.
Executives
Dr. Olaf Stiller Supervisory Board
Andre Schulte-südhoff Supervisory Board
Lisa Jüngst Board of Directors
Michael Tillmann Supervisory Board

NanoRepro AG Headlines

No Headlines